Empagliflozin vs Ranitidine

Empagliflozin vs Ranitidine: Overview

This comparison examines the pharmacological differences between Empagliflozin and Ranitidine.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Ranitidine: Competitive H2 receptor antagonist.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Ranitidine — 2-3 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Ranitidine — C13H22N4O3S.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Ranitidine — 314.4050 g/mol.

Type: Empagliflozin — Small molecule; Ranitidine — Small molecule.